Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Twelve Bio logo — Twelve Bio has developed a diagnostic tool using CRISPR-Cas1...

Twelve Bio

Twelve Bio has developed a diagnostic tool using CRISPR-Cas12a to detect and modify DNA sequences.

Founded 2019 Grant Total: $519.00K Analytics, Biotechnology +1

General Information

Company Name Twelve Bio
Founded Year 2019
Industries Analytics, Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when Twelve Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Twelve Bio

Twelve Bio is a biotechnology startup founded in 2019, offering a groundbreaking diagnostic tool utilizing CRISPR-Cas12a technology to detect and modify DNA sequences.

Twelve Bio specializes in the development of diagnostic technology using CRISPR-Cas12a, capable of detecting and modifying any DNA sequence. The CRISPR-Cas12a system encompasses an RNA-protein complex that enables the identification and modification of specific DNA sequences. The RNA component acts as a search engine to pinpoint the specific DNA sequence, while the protein functions as a biological scissor to cleave it. Leveraging their structural-based rational design insights into the CRISPR gene editing system, Twelve Bio can manipulate and refine the system's activity to meet therapeutic objectives effectively.

The company received a significant $519.00K grant investment on 1st November 2019. This investment underlines the potential and promise of Twelve Bio's innovative approach within the biotechnology industry. With dedicated efforts and visionary technology, Twelve Bio is on a trajectory to revolutionize the field of genetic diagnostics and therapeutics.

Taxonomy: CRISPR-Cas12a, diagnostic technology, DNA sequencing, gene editing, RNA-protein complex, structural-based design, therapeutic objectives

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 01 Nov 2019

Twelve Bio Alternatives & Competitors

Twelve Bio vs
Aptean GenomeQuest
Aptean GenomeQuest United States

When you want to use a DNA, RNA, or protein molecule as a query to search the patent domain, choose...

Series Unknown
10 employees
Health Care, Life Sciences
Twelve Bio vs
Integra Therapeutics
Integra Therapeutics Spain

Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to c...

Seed
23 employees
Biotechnology, Health Care
Twelve Bio vs
Zafrens
Zafrens United States

Opening doors to new insights at the interface of biology, chemistry and engineering

Series A
30 employees

FAQ About Twelve Bio

Twelve Bio has developed a diagnostic tool using CRISPR-Cas12a to detect and modify DNA sequences.
Twelve Bio was founded in 2019.
Twelve Bio operates in the following industries: Analytics, Biotechnology, Health Care.
Twelve Bio has completed 1 funding round, raising a total of $519.00K. The latest funding stage is Grant.
Top alternatives and competitors to Twelve Bio include Aptean GenomeQuest, Integra Therapeutics, Zafrens, 454 Life Sciences, BioVentures Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Twelve Bio and Aptean GenomeQuest are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Twelve Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy